JANE STREET GROUP, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is and the CUSIP is 09627Y909. A total of 4 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$157,391,134
+170.7%
1,460,300
+138.3%
0.04%
+200.0%
Q1 2024$58,139,694
+18.7%
612,900
+15.4%
0.01%
-7.7%
Q4 2023$48,988,664
+1343.0%
531,100
+685.7%
0.01%
+1200.0%
Q3 2023$3,394,872
-10.8%
67,600
+12.3%
0.00%0.0%
Q2 2023$3,804,640
-42.4%
60,200
-59.0%
0.00%
-66.7%
Q1 2023$6,609,031
+52.8%
146,900
+48.8%
0.00%
+50.0%
Q4 2022$4,324,047
-38.3%
98,700
-7.1%
0.00%
-33.3%
Q3 2022$7,004,000
+207.5%
106,300
+135.7%
0.00%
+200.0%
Q2 2022$2,278,00045,1000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 112$874,0000.09%
GROUP ONE TRADING, L.P. 4,200$328,0000.00%
SIMPLEX TRADING, LLC 84$655,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 30,000$2,342,0000.00%
View complete list of BLUEPRINT MEDICINES CORP shareholders